what are the Recommendations for Interruption and Bridging Anticoagulation
Referenced studies that support new or modified recommendations
are summarized in Online Data Supplement 3.?
Idarucizumab is recommended for the reversal of dabigatran in the event of life-threatening bleeding or an urgent procedure.S4.3-2 NEW: New evidence has been published about idarucizumab to support LOE B-NR.